Adherence in a Phase 3 Trial of a Multipurpose Vaginal pH-Regulator vs Nonoxynol-9 [2M]
Skip to main content
Open Access Publications from the University of California

UC Davis

UC Davis Previously Published Works bannerUC Davis

Adherence in a Phase 3 Trial of a Multipurpose Vaginal pH-Regulator vs Nonoxynol-9 [2M]


INTRODUCTION:: The multipurpose vaginal pH-regulator (MVP-R) is a water-based, petroleum-free vaginal gel which is acid-buffering and under investigation for prevention of pregnancy and sexually transmitted infections. We assessed treatment adherence in a phase 3 contraceptive trial comparing the MVP-R and nonoxynol-9 (N-9) spermicidal gel. METHODS:: This randomized, open-label, non-inferiority study was conducted at 62 sites in the U.S. and Russia; all sites obtained IRB-approval and all subjects provided informed consent. The MVP-R (Amphora®, formerly known as Acidform) and N-9 were provided in pre-filled, single-use applicators. Women were instructed to use 1 applicator immediately before or up to 1 hour before vaginal intercourse, and to reapply product if more than 1 hour elapsed and for additional intercourse within 1 hour. Subjects recorded product use and coital activity on a daily diary. RESULTS:: The 3,324 enrollees included 1,665 MVP-R and 1,659 N-9 subjects. Baseline characteristics were similar between treatment arms; characteristics of the overall Intent-to-Treat population included mean age 27.6±5.6 years, body mass index 27.8±8.0 kg/m2 (32.8% obese), 62.0% White, and 76.6% non-Hispanic. The study method was used as the only contraceptive method and used correctly in 85.6% of coital acts (85.9% MVP-R, 85.3% N-9). Overall, 61.5% of all subjects (63.0% MVP-R, 60.1% N-9) were adherent with the proper method use for ≥90% of coital acts. The most common reason for non-adherence was failure to reapply with additional acts of intercourse within 1 hour after application (390/2,935 [13.3%]). CONCLUSION:: Most subjects used these on-demand, women-controlled products as directed. Adherence was similar between the two treatment groups.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View